Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii

International Immunopharmacology

Volumn 7, Issue 2, 2007, Pages 175-182

  Xu, Han ^a   Zhang, Yunyi ^a   Zhang, Jianwen ^b   Chen, Daofeng ^a  

^a FUDAN UNIVERSITY   (China)

^b BIOCRYST PHARMACEUTICALS INC   (United States)

Author keywords

Bupleurum smithii; Complement; Depleted serum; Hemolysis; Inhibition; Polysaccharide

Indexed keywords

ARABINOSE; BUPLEURUM ROOT; COMPLEMENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C9; COMPLEMENT INHIBITOR; GALACTOSE; POLYSACCHARIDE; POLYSACCHARIDE D3 S1; RHAMNOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BUPLEURUM; BUPLEURUM SMITHII; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG MECHANISM; FUNCTIONAL ASSESSMENT; HEMOLYSIS; INHIBITION KINETICS; MEDICINAL PLANT; METHYLATION; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ANIMALS; BUPLEURUM; COMPLEMENT INACTIVATING AGENTS; DRUGS, CHINESE HERBAL; ERYTHROCYTES; HEMOLYSIS; PLANT ROOTS; POLYSACCHARIDES; SHEEP; WATER;

EID: 33845951919     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.006     Document Type: Article

References (35)

1. Makrides S.C. Therapeutic inhibition of the complement system. Pharmacol Rev 50 (1998) 59-87
2. Lustep H.L., and Clark W.M. Current status of neuroprotective agents in the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 1 1 (2001) 13-18
3. Navarro P., Giner R.M., Recio M.C., Manez S., Cerda-Nicolas M., and Rios J.L. In vivo anti-inflammatory activity of saponins from Bupleurum rotundifolium. Life Sci 68 10 (2001) 1199-1206
4. Abe H., Orita M., Konishi H., Arichi S., and Odashima S. Effects of saikosaponin-d on amino nucleoside nephrosis in rats. Eur J Pharmacol 120 2 (1986) 171-178
5. Ushio Y., Oda Y., and Abe H. Effect of saikosaponin on the immune responses in mice. Int J Immunopharmacol 13 5 (1991) 501-508
6. Zhao Y., Tao S., and Xing Y. Studies on the pharmacological actions of Bupleurum smithii. Zhong Yao Cai 18 8 (1995) 405-408
7. Zhao Y., Tao S., Wang Y., and Sun H. The further studies on the pharmacological actions of Bupleurum smithii. Zhong Yao Cai 21 6 (1998) 307-309
8. Guo J.X., Pan S.L., Li Y., Hong X.K., and Wang Z.H. A study on the chemical constituents of volatile oils from l9 species of the genus Bupleurum in China. Acta Acad Med Shanghai 17 4 (1990) 278-282
9. Xu X.Z., Wang Y.H., and Ying G. The quantitative analysis of sterols in Bupleurum smithii. J Ningxia Med Coll 22 6 (2000) 404-408
10. Nelson R.A., Jensen J., Gigli I., and Tamura N. Methods for the separation, purification and measurement of the nine components of hemolytic complement of guinea pig serum. Immunochemistry 3 (1966) 111-135
11. Dubios M., Gilles K.A., Hamilton J.K., Rebers P.A., and Smith F. Colorimetric method for determination of sugar and related substances. Anal Chem 28 (1956) 250-256
12. Blumenkranz N., and Asboe-hansen G. New method for quantitative determination of uronic acids. Anal Biochem 54 (1973) 484-489
13. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
14. Craige J.S., Wen Z.C., and Meer J.P. Intraspecific and nutritionally-determined variations in the composition of agars from Gracilaria spp. Bot Mar 27 (1981) 55-61
15. Taylor R.L., and Conrad H.E. Stoichiometric depolymerization of polyuronides and glycosaminoglycuronans to monosaccharides following reduction of their carbodiimide-activated carboxyl groups. Biochemistry 11 8 (1972) 1383-1388
16. Jones T.M., and Albersheim P. A gas chromatographic method for the determination of aldose and uronic acid constituents of plant cell wall polysaccharides. Plant Physiol 49 (1972) 926-936
17. Ciucanu I., and Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131 (1984) 209-217
18. Mayer M.M. Complement and complement fixation. In: Kabat E.A., and Mayer M.M. (Eds). Experimental immunochemistry. 2nd ed. (1961), Springfield Publications 133-240
19. Klerx J.P., Beukelman C.J., Van D.H., and Willers J.M. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods 63 2 (1983) 215-220
20. Zhou J., Zhang Y.Y., Zhang JW., Xu H., and Chen D.F. The effect of traditional Chinese medicine Eucommia ulmoides on complement system. J. Fudan University (Medical Sciences) 33 1 (2006) 101-106
21. Stancioff D.J., and Stanley N.F. Infrared and chemical studies on algal polysaccharides. Proc Int Seaweed Symp 6 (1969) 595-609
22. Sun H.H., Wooten J.B., Ryan W.S., Bokelman J.G.H., and Aman P. Structural characterization of a tobacco rhamnogalacturonan. Carbohydr Polym 7 (1987) 143-158
23. Volanakis J.E. Overview of the complement system. In: Volonakis J.E., and Frank M.M. (Eds). The human complement system in health and diseases (1998), Marcel-Dekker, New York 9-32
24. Hugli T.E. Biochemistry and biology of anaphylatoxins. Complement 3 3 (1986) 111-127
25. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology 38 1-2 (1997) 51-62
26. Morgan B.P., and Harris C.L. Complement therapeutics; history and current progress. Mol Immunol 40 (2003) 159-170
27. Zhang Y., Kiyohara H., Matsumoto T., and Yamada H. Fractionation and chemical properties of immunomodulating polysaccharides from roots of Dipsacus asperoide. Planta Med 63 (1997) 393-399
28. Cimanga K., De B.T., Lasure A., Van P.B., Pieters L., Vanden B., et al. In vitro anti-complementary activity of constituents from Morinda morindoides. J Nat Prod 58 3 (1995) 372-378
29. Lee S.M., Kim J.H., Zhang Y., An R.B., Min B.S., Joung H., et al. Anticomplementary activity of protostane-type triterpenes from Alismatis rhizoma. Arch Pharm Res 26 6 (2003) 463-465
30. Ling M., Piddlesden S.J., and Morgan B.P. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement. Clin Exp Immunol 102 3 (1995) 582-588
31. Weiler J.M., Edens R.E., Linhardt R.J., and Kapelanski D.P. Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148 10 (1992) 3210-3215
32. Jaques L.B. Heparin: an old drug with a new paradigm. Science 206 (1979) 528-533
33. Laurent T.C., Tengblad A., Thunberg L., Hook M., and Lindahl U. The molecular weight dependence of the anticoagulant activity of heparin. Biochem J 175 (1978) 691-701
34. Cofrancesco E., Radaelli F., Pogliani E., Amici N., Torri G.G., and Casu B. Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities. Thromb Res 14 1 (1979) 179-187
35. Holers V.M. The complement system as a therapeutic target in autoimmunity. Clin Immunol 107 3 (2003) 140-151